Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
J Neurol Sci ; 336(1-2): 127-31, 2014 Jan 15.
Article in English | MEDLINE | ID: mdl-24183854

ABSTRACT

OBJECTIVES: Despite the high mortality, there is currently no specific treatment for intracerebral hemorrhage (ICH). Research investigating optimum degree of blood pressure control in patients presenting with ICH and hypertension is ongoing. However, there is limited understanding of the potential benefits of specific classes of antihypertensive therapy. ß-Adrenergic antagonists may provide neuroprotection from inflammation-induced injury by inhibiting sympathetic nervous system mediated immune activation. We examined mortality in ICH patients receiving ß-adrenergic antagonists to determine whether this class of antihypertensive therapy was associated with improved survival. METHODS: A retrospective analysis of a large, prospectively collected database of patients presenting with acute ICH was performed. Patients were grouped by inpatient ß-blocker treatment to determine an effect on mortality during the inpatient stay and at 3 months of follow-up. Additional analysis was conducted comparing ß-blocker therapy to any other antihypertensive treatment to determine a class-specific association of ß-blocker treatment with mortality. RESULTS: The study population included 426 patients with acute, spontaneous ICH. Inpatient ß-blocker use was independently associated with decreased rates of inpatient death and mortality at 3 months of follow-up. However, univariate and multivariable analyses comparing ß-blocker use to other antihypertensives failed to show any class-specific reduction in mortality at either time point. DISCUSSION: Our study demonstrates that the improvement seen in patients treated with ß-adrenergic antagonists is not an effect unique to this class. This supports ongoing trials to determine optimum levels of blood pressure control using multiple classes of antihypertensives.


Subject(s)
Adrenergic beta-Antagonists/therapeutic use , Cerebral Hemorrhage/drug therapy , Cerebral Hemorrhage/mortality , Acute Disease , Aged , Aged, 80 and over , Cerebral Hemorrhage/diagnosis , Cohort Studies , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prospective Studies , Retrospective Studies , Survival Rate/trends
9.
Altern Med Rev ; 6(6): 539, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11804545
10.
11.
Altern Med Rev ; 5(3): 195, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10869100
14.
Altern Med Rev ; 4(2): 73, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10231606
17.
Altern Med Rev ; 3(5): 337, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9802910
18.
Altern Med Rev ; 3(4): 261, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9727077
SELECTION OF CITATIONS
SEARCH DETAIL
...